Krystal Biotech, Inc. Common Stock (NASDAQ: KRYS) last traded at $346.58, up 2.84% on the session. The quote above updates while this page is open; the figures below are drawn from Krystal Biotech, Inc. Common Stock’s own filings and are restated only when a new one is published.
Krystal Biotech, Inc. Common Stock trades on NASDAQ under the ticker KRYS. Its market capitalisation is $10.26 billion.
Valuation measures for Krystal Biotech, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $10.26B |
|---|---|
| Enterprise value | $9.97B |
| P/E ratio | 43.49 |
| Price / sales | 23.29 |
| Price / book | 7.55 |
| Beta | 0.81 |
Trailing-twelve-month figures tagged in Krystal Biotech, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $440.48M |
|---|---|
| Net income (TTM) | $241.47M |
| EPS (TTM) | $7.97 |
| Operating margin | 44.89% |
| Return on equity | 17.77% |
| Cash | $427.74M |
Range and volume for KRYS over the past 52 weeks.
| 52-week high | $382.54 |
|---|---|
| 52-week low | $136.73 |
| Volume | 407.8K |
| Average volume | 409.6K |
| Previous close | $337.02 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.